Dr. Richard Childs
Dr. Richard Childs earned his M.D. from Georgetown University in 1991. He completed his internship, residency, and chief residency in Internal Medicine at the University of Florida. In 2009, after just four years of active duty in the United States Commissioned Corps, he rose to the rank of Captain.
In 2013, Dr. Childs assumed the title of Director of the National Heart, Lung and Blood Institute (NHLBI) Division of Intramural Research (DIR). His supervision supports over 180 active clinical research protocols, 650 inpatient admissions, and 14,000 outpatient visits. Additionally, Dr. Childs became Section Chief and Senior Investigator in the Laboratory of Transportation Immunotherapy. Here, the focus of research on allogeneic stem cell transportation and tumor immunology helps to treat aplastic anemia, hematological malignancies, and solid tumors. “He was the first to establish the existence of the graft-vs-solid tumor effect mediated by transplanted donor T-cells that could cure patients with metastatic renal cell carcinoma,” according to the National Heart, Lung, and Blood Institute.
Dr. Richard Childs deployed to Monrovia, Liberia, as Chief Medical Officer from 2014 to 2015 as part of the United States Ebola crisis response in West Africa. There, he served as the Chief Medical Officer of the Monrovia Medical Unit, caring for Ebola patients.
In September 2015, Dr. Childs ascended to the rank of Rear Admiral in the US Public Health Service, with the title of Assistant Surgeon General.
Among his many awards in 2010, Dr. Childs received the highest award from the United States Public Health Service, the Distinguished Service Medal from the United States Surgeon General for research that has improved the field of hematopoietic stem cell transplantation.
Dr. Childs currently resides in Maryland with his wife and family.